HCA RSI Chart
Last 7 days
4.2%
Last 30 days
-2.2%
Last 90 days
5.0%
Trailing 12 Months
15.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 66.7B | 0 | 0 | 0 |
2023 | 60.9B | 61.9B | 63.2B | 65.0B |
2022 | 59.7B | 60.1B | 59.8B | 60.2B |
2021 | 52.6B | 56.0B | 58.0B | 58.8B |
2020 | 51.7B | 50.1B | 50.8B | 51.5B |
2019 | 47.8B | 48.8B | 50.1B | 51.3B |
2018 | 44.4B | 45.2B | 46.0B | 46.7B |
2017 | 41.1B | 40.7B | 40.3B | 43.6B |
2016 | 44.3B | 44.5B | 44.6B | 41.5B |
2015 | 40.8B | 42.5B | 43.5B | 43.6B |
2014 | 38.4B | 39.2B | 40.7B | 39.3B |
2013 | 35.9B | 36.2B | 35.8B | 38.0B |
2012 | 30.7B | 31.5B | 33.2B | 35.9B |
2011 | 27.9B | 27.4B | 27.0B | 29.7B |
2010 | 0 | 0 | 0 | 28.0B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 08, 2024 | cuffe michael s. | gifted | - | - | -4,500 | evp and chief clinical officer |
May 07, 2024 | cuffe michael s. | acquired | 2,594,860 | 139 | 18,660 | evp and chief clinical officer |
May 07, 2024 | cuffe michael s. | sold (taxes) | -3,883,140 | 314 | -12,349 | evp and chief clinical officer |
May 06, 2024 | cuffe michael s. | sold | -494,400 | 309 | -1,600 | evp and chief clinical officer |
May 03, 2024 | torres kathryn a. | sold | -277,680 | 312 | -890 | svp-payer contracting & align. |
May 02, 2024 | torres kathryn a. | sold | -303,576 | 312 | -973 | svp-payer contracting & align. |
May 01, 2024 | marks mike a | gifted | - | - | -566 | evp and cfo |
Apr 29, 2024 | deparle nancy ann | acquired | - | - | 610 | - |
Apr 29, 2024 | frist thomas f iii | acquired | - | - | 1,284 | - |
Which funds bought or sold HCA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 08, 2024 | Russell Investments Group, Ltd. | reduced | -5.33 | 26,373,200 | 184,874,000 | 0.29% |
May 08, 2024 | EDMOND DE ROTHSCHILD HOLDING S.A. | unchanged | - | 17,912 | 95,056 | -% |
May 08, 2024 | Interchange Capital Partners, LLC | reduced | -12.54 | 18,344 | 253,645 | 0.17% |
May 08, 2024 | ANGELES WEALTH MANAGEMENT, LLC | new | - | 203,453 | 203,453 | 0.02% |
May 08, 2024 | Humankind Investments LLC | reduced | -13.16 | 93,008 | 1,421,500 | 0.38% |
May 08, 2024 | PROFUND ADVISORS LLC | reduced | -2.74 | 172,335 | 1,040,950 | 0.04% |
May 08, 2024 | AVANTAX ADVISORY SERVICES, INC. | added | 11.03 | 465,188 | 1,728,920 | 0.01% |
May 08, 2024 | Waverton Investment Management Ltd | added | 10.00 | 11,167,800 | 42,660,700 | 0.89% |
May 08, 2024 | KBC Group NV | reduced | -48.43 | -36,112,000 | 62,953,000 | 0.20% |
May 08, 2024 | Bell Investment Advisors, Inc | added | 9.35 | 10,061 | 39,024 | 0.01% |
Unveiling HCA Healthcare Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to HCA Healthcare Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 466.7B | 379.5B | 30.38 | 1.23 | ||||
CI | 99.7B | 206.0B | 25.87 | 0.48 | ||||
HCA | 84.3B | 66.7B | 15.4 | 1.26 | ||||
CVS | 69.9B | 360.9B | 9.54 | 0.19 | ||||
CNC | 41.4B | 155.5B | 15.15 | 0.27 | ||||
DVA | 12.1B | 12.3B | 14.83 | 0.98 | ||||
UHS | 11.9B | 14.7B | 14.57 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.7B | 2.3B | 30.63 | 3.79 | ||||
ACHC | 6.5B | 3.0B | -578.78 | 2.19 | ||||
AMN | 2.3B | 3.8B | 10.95 | 0.61 | ||||
AMEH | 2.2B | 1.5B | 35.09 | 1.51 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.45 | 1.6 | ||||
BKD | 1.4B | 3.0B | -7.95 | 0.45 | ||||
BEAT | 52.9M | - | -3.5 | - | ||||
AMS | 19.9M | 21.3M | 37.29 | 0.93 |
HCA Healthcare Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 0.2% | 17,339 | 17,303 | 16,213 | 15,861 | 15,591 | 15,497 | 14,971 | 14,820 | 14,945 | 15,064 | 15,276 | 14,435 | 13,977 | 14,293 | 13,311 | 11,068 | 12,861 | 13,523 | 12,694 | 12,602 | 12,517 |
Costs and Expenses | 0.9% | 15,092 | 14,958 | 14,583 | 14,052 | 13,669 | 12,195 | 13,267 | 13,060 | 13,131 | 12,478 | 12,119 | 12,318 | 12,004 | 12,221 | 12,323 | 9,508 | 12,051 | 11,916 | 11,715 | 11,404 | 11,057 |
EBITDA Margin | 0.4% | 0.20* | 0.20* | 0.22* | 0.22* | 0.22* | 0.22* | 0.21* | 0.23* | 0.24* | 0.24* | 0.24* | 0.20* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 4.3% | 512 | 491 | 483 | 485 | 479 | 453 | 446 | 434 | 408 | 398 | 398 | 386 | 384 | 383 | 385 | 388 | 428 | 438 | 448 | 477 | 461 |
Income Taxes | -8.1% | 445 | 484 | 355 | 397 | 379 | 656 | 360 | 381 | 349 | 581 | 685 | 453 | 393 | 378 | 209 | 344 | 112 | 334 | 215 | 271 | 279 |
Earnings Before Taxes | -4.2% | 2,247 | 2,345 | 1,630 | 1,809 | 1,922 | 3,302 | 1,704 | 1,760 | 1,814 | 2,586 | 3,157 | 2,117 | 1,973 | 2,072 | 988 | 1,560 | 810 | 1,607 | 979 | 1,198 | 1,460 |
EBT Margin | 1.5% | 0.12* | 0.12* | 0.14* | 0.14* | 0.14* | 0.14* | 0.13* | 0.16* | 0.16* | 0.17* | 0.16* | 0.13* | - | - | - | - | - | - | - | - | - |
Net Income | -1.0% | 1,591 | 1,607 | 1,079 | 1,193 | 1,363 | 2,081 | 1,134 | 1,155 | 1,273 | 1,814 | 2,269 | 1,450 | 1,423 | 1,426 | 668 | 1,079 | 581 | 1,071 | 612 | 783 | 1,039 |
Net Income Margin | 1.6% | 0.08* | 0.08* | 0.09* | 0.09* | 0.09* | 0.09* | 0.09* | 0.11* | 0.11* | 0.12* | 0.11* | 0.09* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -10.8% | 1,351 | 1,515 | 1,332 | 1,234 | 606 | 1,204 | 1,889 | 550 | 484 | 1,251 | 1,388 | 1,409 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 1.3% | 56,962 | 56,211 | 54,589 | 53,594 | 52,711 | 52,438 | 51,484 | 51,584 | 52,208 | 50,742 | 49,562 | 48,164 | 47,277 | 47,490 | 51,016 | 48,709 | 45,421 | 45,058 | 43,912 | 45,449 | 43,379 |
Current Assets | 2.4% | 15,282 | 14,927 | 14,294 | 13,888 | 13,541 | 13,643 | 13,481 | 13,937 | 15,006 | 13,542 | 13,248 | 12,475 | 12,036 | 12,333 | 16,266 | 14,031 | 11,016 | 11,196 | 10,769 | 12,869 | 11,108 |
Cash Equivalents | 37.3% | 1,284 | 935 | 891 | 862 | 842 | 908 | 999 | 858 | 2,371 | 1,451 | 1,027 | 1,120 | 1,030 | 1,793 | 6,588 | 4,638 | 731 | 621 | 559 | 2,430 | 531 |
Inventory | -5.8% | 1,903 | 2,021 | 2,030 | 2,050 | 2,085 | 2,068 | 2,009 | 2,043 | 2,003 | 1,986 | 2,019 | 2,027 | 2,068 | 2,025 | 1,950 | 1,834 | 1,953 | 1,849 | 1,769 | 1,826 | 1,778 |
Net PPE | 1.4% | 28,096 | 27,715 | 27,117 | 26,644 | 26,053 | 25,575 | 24,978 | 24,587 | 24,228 | 24,063 | 23,547 | 23,471 | 23,188 | 23,199 | 22,941 | 23,071 | 22,985 | 22,715 | 22,002 | 21,467 | 21,128 |
Current Liabilities | 3.8% | 13,141 | 12,655 | 12,407 | 11,545 | 11,028 | 9,902 | 9,784 | 8,999 | 10,518 | 9,582 | 9,624 | 8,615 | 8,642 | 8,704 | 14,379 | 12,856 | 7,019 | 7,757 | 7,124 | 8,961 | 10,531 |
Long Term Debt | 0.0% | 37,163 | 37,169 | 36,793 | 36,537 | 36,478 | 37,714 | 37,492 | 38,657 | 36,210 | 34,342 | 32,049 | 32,319 | 30,838 | 30,795 | 30,792 | 30,779 | 34,699 | 33,577 | 34,097 | 34,120 | 31,019 |
LT Debt, Current | 24.9% | 3,028 | 2,424 | 2,553 | 2,395 | 2,378 | 370 | 218 | 246 | 1,486 | 237 | 250 | 253 | 234 | 209 | 172 | 163 | 162 | 145 | 148 | 2,073 | 3,796 |
LT Debt, Non Current | -100.0% | - | 37,169 | 36,793 | 36,537 | 36,478 | 37,714 | 37,492 | 38,657 | 36,210 | 34,342 | 32,049 | 32,319 | 30,838 | 30,795 | 30,792 | 30,779 | 34,699 | 33,577 | 34,097 | 34,120 | 31,019 |
Shareholder's Equity | 19.8% | 1,270 | 1,060 | 357 | 461 | 232 | -73.00 | - | - | 414 | 1,489 | 1,825 | 1,790 | 2,482 | 2,892 | 1,299 | 568 | - | - | - | - | - |
Retained Earnings | 12.4% | -1,185 | -1,352 | -1,989 | -1,850 | -2,028 | -2,280 | -2,781 | -3,168 | -1,589 | -532 | -206 | -121 | 735 | 777 | -647 | -1,315 | -2,394 | -2,351 | -3,107 | -3,474 | -3,983 |
Additional Paid-In Capital | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 294 | 185 | 88.00 | - | - | - | - | - |
Accumulated Depreciation | 1.7% | 31,344 | 30,833 | 30,655 | 30,023 | 29,410 | 29,182 | 28,752 | 28,229 | 27,814 | 27,287 | 27,148 | 27,227 | 26,689 | 26,118 | 25,834 | 25,413 | 24,876 | 24,520 | 24,293 | 23,902 | 23,455 |
Shares Outstanding | -0.9% | 263 | 266 | 269 | 273 | 276 | 277 | 286 | 293 | 302 | 323 | 328 | 333 | - | - | - | - | - | - | - | - | - |
Minority Interest | 1.8% | 2,885 | 2,834 | 2,834 | 2,764 | 2,727 | 2,694 | 2,592 | 2,538 | 2,447 | 2,422 | 2,520 | 2,383 | 2,235 | 2,320 | 2,273 | 2,354 | 2,259 | 2,243 | 2,118 | 2,132 | 2,099 |
Float | - | - | - | - | 61,126 | - | - | - | 36,171 | - | - | - | 51,895 | - | - | - | 25,836 | - | - | - | 36,403 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -7.7% | 2,469 | 2,674 | 2,479 | 2,475 | 1,803 | 2,527 | 3,020 | 1,630 | 1,345 | 2,443 | 2,277 | 2,251 | 1,988 | -3,583 | 2,717 | 8,723 | 1,375 | 2,505 | 2,126 | 1,997 | 974 |
Share Based Compensation | 52.6% | 87.00 | 57.00 | 72.00 | 56.00 | 77.00 | 83.00 | 87.00 | 85.00 | 86.00 | 99.00 | 115 | 129 | 97.00 | 133 | 81.00 | 66.00 | 82.00 | 84.00 | 105 | 96.00 | 62.00 |
Cashflow From Investing | 43.5% | -903 | -1,597 | -1,312 | -1,257 | -1,151 | -793 | -546 | -1,205 | -845 | -1,714 | 640 | -920 | -649 | -910 | -530 | -808 | -1,145 | -1,345 | -1,262 | -948 | -2,165 |
Cashflow From Financing | -17.0% | -1,216 | -1,039 | -1,132 | -1,198 | -725 | -1,838 | -2,317 | -1,926 | 425 | -306 | -3,003 | -1,242 | -2,104 | -316 | -245 | -4,007 | -109 | -1,110 | -2,731 | 854 | 1,216 |
Dividend Payments | 15.6% | 185 | 160 | 162 | 164 | 175 | 156 | 160 | 160 | 177 | 148 | 151 | 156 | 169 | - | - | 1.00 | 152 | 136 | 136 | 137 | 141 |
Buy Backs | 29.3% | 1,187 | 918 | 1,151 | 924 | 849 | 1,519 | 698 | 2,682 | 2,101 | 2,072 | 2,329 | 2,287 | 1,527 | - | - | - | 441 | 272 | 239 | 242 | 278 |
Condensed Consolidated Income Statements (Unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenues | $ 17,339 | $ 15,591 |
Salaries and benefits | 7,707 | 7,084 |
Supplies | 2,671 | 2,423 |
Other operating expenses | 3,606 | 2,894 |
Equity in losses of affiliates | 2 | 18 |
Depreciation and amortization | 795 | 756 |
Interest expense | 512 | 479 |
Losses (gains) on sales of facilities | (201) | 15 |
Total expenses including equity in earnings of affiliates | 15,092 | 13,669 |
Income before income taxes | 2,247 | 1,922 |
Provision for income taxes | 445 | 379 |
Net income | 1,802 | 1,543 |
Net income attributable to noncontrolling interests | 211 | 180 |
Net income attributable to HCA Healthcare, Inc. | $ 1,591 | $ 1,363 |
Per share data: | ||
Basic earnings | $ 6.01 | $ 4.92 |
Diluted earnings | $ 5.93 | $ 4.85 |
Shares used in earnings per share calculations (in millions): | ||
Basic | 264,435 | 276,910 |
Diluted | 268,016 | 280,961 |
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,284 | $ 935 |
Accounts receivable | 10,044 | 9,958 |
Inventories | 1,903 | 2,021 |
Other | 2,051 | 2,013 |
Total current assets | 15,282 | 14,927 |
Property and equipment, at cost | 59,440 | 58,548 |
Accumulated depreciation | (31,344) | (30,833) |
Property and equipment, net | 28,096 | 27,715 |
Investments of insurance subsidiaries | 471 | 477 |
Investments in and advances to affiliates | 736 | 756 |
Goodwill and other intangible assets | 9,967 | 9,945 |
Right-of-use operating lease assets | 2,211 | 2,207 |
Other | 199 | 184 |
Total assets | 56,962 | 56,211 |
Current liabilities: | ||
Accounts payable | 4,735 | 4,233 |
Accrued salaries | 1,759 | 2,127 |
Other accrued expenses | 3,619 | 3,871 |
Long-term debt due within one year | 3,028 | 2,424 |
Total current liabilities | 13,141 | 12,655 |
Long-term debt, less debt issuance costs and discounts of $381 and $333 | 37,163 | 37,169 |
Professional liability risks | 1,571 | 1,557 |
Right-of-use operating lease obligations | 1,912 | 1,903 |
Income taxes and other liabilities | 1,905 | 1,867 |
Stockholders equity: | ||
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 263,215,800 shares - 2024 and 265,537,300 shares - 2023 | 3 | 3 |
Accumulated other comprehensive loss | (433) | (425) |
Retained deficit | (1,185) | (1,352) |
Stockholders' deficit attributable to HCA Healthcare, Inc. | (1,615) | (1,774) |
Noncontrolling interests | 2,885 | 2,834 |
Total stockholders' equity | 1,270 | 1,060 |
Total liabilities and stockholders' equity | $ 56,962 | $ 56,211 |
 | Mr. Samuel N. Hazen |
---|---|
 | hcahealthcare.com |
 | Healthcare Plans |
 | 65535 |